We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
+24.27%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$600M
AUM Growth
+$109M
Cap. Flow
+$3.17M
Cap. Flow %
0.53%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AST
Asterias Biotherapeutics Inc. Series A
AST
+$3.17M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 58.91%
2 Consumer Staples 36.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$94.3B
$221M 36.91%
9,594,816
– –
MNK
2
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$205M 34.22%
1,619,968
– –
LCTX icon
3
Lineage Cell Therapeutics
LCTX
$269M
$88.6M 14.78%
22,095,035
– –
STAA icon
4
STAAR Surgical
STAA
$1.21B
$55.1M 9.19%
7,417,582
– –
CYNO
5
DELISTED
Cynosure, Inc. Class A
CYNO
$25.1M 4.18%
817,029
– –
AST
6
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$4.32M 0.72%
+641,025
New +$3.17M

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q1 2015 Portfolio in Review

As of Q1 2015, Broadwood Capital held 6 positions worth $600M, up 22% from $490M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital's Q1 2015 filing shows 1 new position. Its largest new stake was Asterias Biotherapeutics Inc. Series A: 641,025 shares worth $4.32M.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 60% a quarter earlier, followed by Consumer Staples.

  • Broadwood Capital's largest Q1 2015 buy was Asterias Biotherapeutics Inc. Series A: 641,025 shares worth $4.32M.
  • Broadwood Capital's ten largest holdings make up 100% of its $600M portfolio in Q1 2015.
  • Broadwood Capital opened 1 new position and closed 0 in Q1 2015.
  • Broadwood Capital's portfolio value rose 22% quarter-over-quarter to $600M.

Based on Broadwood Capital's 13F filing for Q1 2015, filed 15 May 2015.